Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Ayurvedic plants may help treat PCOD by affecting hormones and ovarian health.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Both estrogens and androgens are important for health in both males and females.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

More research is needed to understand how testosterone is maintained in adult males.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Testosterone use for muscle growth can cause hair loss in males.

Higher DHT levels are linked to more acne in adolescents, especially boys.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone affects brain behavior in complex and varied ways.